Stock Rich List
#7605 on the rich list of 14,644 insiders

James C. Momtazee

Director at BridgeBio Pharma; Director at Roivant Sciences.

$12.1M
in disclosed stock, +$43K (+0.35%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
Rank
7605th of 14,644
Companies held
2
Largest holding
BBIO, 63.9% of total
Latest SEC filing
Oct 23, 2026

What the $12.1M is made of

Holdings counted

All filings on SEC.gov
CompanyHow heldSharesPriceValueShare of totalReported
BridgeBio Pharma BBIO
Common Stock
Through The James Momtazee Revocable Trust80,000$78.18$6.3M51.6%Form 4, Jun 22, 2026
Roivant Sciences ROIV
Common Shares
Directly112,265$38.96$4.4M36.1%Form 4, Oct 23, 2026
BridgeBio Pharma BBIO
Common Stock
Directly19,070$78.18$1.5M12.3%Form 4, Jun 22, 2026

Share counts are the amounts James C. Momtazee reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.

Nearby on the list

Full list
Nearby ranks
RankNameStock holdingsToday
7602Guerrini Martino Scabbia
EVP, Chief Commercial Officer, V.F.. Denver, CO
$12.1M−$627K (−4.91%)
7603Cory T. Newsom
President, South Plains Financial. Lubbock, TX
$12.1M−$186K (−1.51%)
7604Peter Cherecwich
Chief Operating Officer, Northern Trust. Chicago, IL
$12.1M−$353K (−2.83%)
7605James C. Momtazee
Director, BridgeBio Pharma
$12.1M+$43K (+0.35%)
7606Neil J. Fernandes
Senior Vice President, Lam Research. Fremont, CA
$12.1M−$475K (−3.77%)
7607Kevin M. Graney
Vice President, General Dynamics. Bethesda, MD
$12.1M−$61K (−0.50%)
7608William Gordon Stone III
Chief Executive Officer, Digital Turbine. Austin, TX
$12.1M−$682K (−5.33%)

Other BridgeBio Pharma insiders

All BBIO insiders

Questions

How much stock does James C. Momtazee own?

James C. Momtazee holds $12,119,137 in listed stock based on SEC filings and current prices, mostly BridgeBio Pharma (BBIO). That ranks 7605th on the Stock Rich List.

Is this James C. Momtazee's net worth?

No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.